SCHEDULE: HOLD Alapkezelo Zrt. Discloses 10.4% Stake in MediWound Ltd.

HOLD Alapkezelo Zrt. has filed a Schedule 13G, reporting beneficial ownership of 1,348,323 shares, representing 10.4% of MediWound Ltd.'s common stock outstanding as of June 30, 2026.

Summary

• HOLD Alapkezelo Zrt. has filed an amendment to its Schedule 13G, disclosing its beneficial ownership of MediWound Ltd. common shares.
• The filing indicates that HOLD Alapkezelo Zrt. beneficially owns 1,348,323 shares of MediWound Ltd. common stock.
• This ownership represents approximately 10.4% of the issuer's outstanding common stock as of June 30, 2026.
• The information is based on MediWound Ltd.'s 6-K filing dated August 13, 2026, which reported 12,910,278 shares outstanding.
• HOLD Alapkezelo Zrt. has sole voting power and sole dispositive power over these shares.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, primarily indicating a significant but not controlling stake by an institutional investor. The lack of new strategic information or financial performance data tempers a more enthusiastic outlook.

Positives

• Institutional investor HOLD Alapkezelo Zrt. has taken a significant stake (10.4%) in MediWound Ltd., which can signal confidence in the company's future prospects.
• The investor has sole voting and dispositive power, indicating clear control over their investment decisions.

Negatives

• The filing does not provide any new financial performance data or strategic updates for MediWound Ltd., limiting insight into the company's operational health.
• The disclosure is a routine Schedule 13G filing, not an indication of a new investment or a change in strategy by the investor.

Risks

• The filing does not explicitly mention any new risks or challenges for MediWound Ltd. or HOLD Alapkezelo Zrt.

Future Outlook

The filing itself does not contain forward-looking statements or guidance from MediWound Ltd. It solely reports the ownership stake of HOLD Alapkezelo Zrt.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."
• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."

Industry Context

StockSavvy.ai notes that the disclosure of a significant ownership stake by an institutional investor like HOLD Alapkezelo Zrt. is a common event in the life cycle of publicly traded companies. It often indicates a belief in the company's underlying value or potential, but without further context on the investor's strategy or MediWound's performance, its immediate impact is limited.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional investor may be viewed positively, potentially increasing investor confidence. However, the filing itself does not provide information to directly impact share price.
• Management: The filing confirms a substantial shareholder, which could lead to increased engagement or scrutiny from HOLD Alapkezelo Zrt.
• Creditors: No direct impact is indicated by this filing.

Key Dates

Keywords

MediWound Ltd., HOLD Alapkezelo Zrt., Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Shareholder